Manager of “Tipa”, the first population based biobank in Israel, within the Maccabi Healthcare Services institute for research and innovation. Leading all biobank related activities since first devised early-2016. Responsible for planning the execution road-map, facilitating the successful biobank launch and continued scaling-up of biobank activities since then. Daniella has a multi-disciplinary background with a BSc in Psycho-Biology, and an MSc in Business Management & advanced Biology, a combined program of the Hebrew university in Jerusalem. Prior to Maccabi, Daniella worked for 10 years at Teva Pharmaceuticals. During this time she utilized and developed analytical and strategic skills as well as gaining extensive experience in complex project management.
Session Abstract – PMWC 2019 Silicon Valley
Session Synopsis: Biobanking is crucial to biomedicine. Biobanks are changing the face of medical research by making available a wealth of material needed for broad research, to investigate cancerous tissues, allow access to healthy controls, and more. This session features leaders from across several organizations – Astra Zeneca, Duke, Maccabi Research Institute, and Quintiles – discussing the importance, as well as the challenges of biobanking for personalized medicine, touching on various population-based applications, data access policy, and other aspects of building and maintaining a biobank.